Economic Evaluation in Genomic and Precision Medicine 1st Edition

Grab the practical guide transforming how health systems value genomic innovation: Economic Evaluation in Genomic and Precision Medicine, 1st Edition by Christina Mitropoulou, Sarah Wordsworth, James Buchanan, and George Patrinos. This authoritative volume brings rigorous health economics to the fast-moving worlds of genomics and precision medicine.

Explore clear, methodical explanations of cost-effectiveness analysis, decision-analytic modelling, and budget-impact assessment tailored to genomic tests, gene therapies, and personalized treatment pathways. The book balances theoretical foundations with applied examples—covering diagnostic yield, long-term outcomes, and real-world implementation—so readers understand both the numbers and the clinical stakes.

Designed for health economists, policymakers, clinicians, industry stakeholders, and advanced students, this edition explains how to navigate value assessment across settings—from national Health Technology Assessment (HTA) processes in the UK and Europe to payer decisions in the US and resource-constrained environments in Asia and low- and middle-income countries. You’ll find step-by-step guidance on modelling uncertainty, incorporating patient heterogeneity, valuing health outcomes, and translating genomic evidence into actionable policy.

Why this book matters: it equips decision-makers and researchers with tools to assess affordability and impact of precision interventions, helping prioritize investments that improve patient outcomes while maintaining sustainable systems. Written by respected experts, the text is both accessible and technically robust, ideal for those seeking to apply economic evaluation to real-world genomic challenges.

Advance your expertise and influence healthcare decisions—add Economic Evaluation in Genomic and Precision Medicine, 1st Edition to your professional library today.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.